Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 23 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

10 recruiting

Enrollment Performance

Analytics

N/A
17(94.4%)
Phase 2
1(5.6%)
18Total
N/A(17)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT07354633Not ApplicableRecruiting

Full Sail Ahead, Sailing in Psychosocial Rehabilitation.

Role: lead

NCT07317388Recruiting

Group Psychoeducation to Promote Independent Living in Individuals With Psychiatric Disorders

Role: lead

NCT07316803Not ApplicableRecruiting

Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness

Role: lead

NCT06867783Not ApplicableActive Not Recruiting

EVALUATION FOR YOUNG CHILDREN WITH AUTISM SPECTRUM DISORDERS

Role: lead

NCT06595654Not ApplicableRecruiting

Treatment of Negative Symptoms of Schizophrenia by rTMS

Role: lead

NCT06314204Recruiting

Impact of Cannabis Consumption on the Course, Modalities of Hospitalization and the Short-term Prognosis of Inpatients Suffering From Psychotic Symptoms

Role: lead

NCT04784572Not ApplicableRecruiting

Assessment of Pain During Intramuscular Injection Delay in Adult Psychiatry

Role: lead

NCT04352569Not ApplicableRecruiting

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia

Role: lead

NCT06263933Not ApplicableUnknown

Effect of Experience Sharing and Mutual Assistance on Insight and Recovery During the First Psychotic Episode

Role: lead

NCT05784961Not ApplicableNot Yet Recruiting

Impact of tDCS on Cannabis Craving in Schizophrenia

Role: lead

NCT02755623Not ApplicableUnknown

Structural and Functional Correlates of Clinical Response to rTMS Treatment in Schizophrenia Patients With Resistant Auditory Hallucinations

Role: lead

NCT04608032Not ApplicableRecruiting

Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia

Role: lead

NCT02698696Not ApplicableRecruiting

Validation of a Cognitive Remediation Program for Bipolar Disorders

Role: lead

NCT04354935Not ApplicableRecruiting

Treatment of Resistant Depression by Repetitive Transcranial Magnetic Stimulation (rTMS) Multicentric Naturalistic Study

Role: lead

NCT04431765Not ApplicableUnknown

Evaluation of Desensitization Therapy and Re-treatment of Eye Movement Information [EMDR] in Patients With Post-traumatic Stress Disorder [PTSD]

Role: lead

NCT03542903Not ApplicableUnknown

ECT in Ultra-resistant Schizophrenia

Role: collaborator

NCT04354974Not ApplicableUnknown

Evaluation of a Cognitive Remediation Program for Mood Disorders

Role: lead

NCT04357418Completed

Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives

Role: lead

NCT04423809Completed

Impact of Burden in Caregivers of Patients Hospitalized for a Psychotic Episode: a Multicenter Study

Role: lead

NCT04370964Not ApplicableUnknown

Evolution of Family Alliance in Families With a Designated Adolescent Patient (12-18 Years) During a Family Therapy Process

Role: lead